Mackin James P

President & CEO, Director · SEC CIK 1408470
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$17.13M
32 trades
Net flow
−$17.13M
Net selling
Total filings
78
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Mar 4, 2026 ΔOwn −1.9%

Mackin James P sold $675.7K of AORT, trimming their stake 2%.

−$675.7K
17,887 sh @ $38
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Mar 3, 2026 ΔOwn −1.7%

Mackin James P sold $567K of AORT, trimming their stake 2%.

−$567K
14,911 sh @ $38
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 25, 2026 ΔOwn −1.8%

Mackin James P sold $497.4K of AORT, trimming their stake 2%.

−$497.4K
13,936 sh @ $36
Advertisement
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 25, 2026 ΔOwn −2.6%

Mackin James P sold $787.9K of AORT, trimming their stake 3%.

−$787.9K
20,962 sh @ $38
AORT
Option exercise Mackin James P · President & CEO · Option exercise · filed Dec 4, 2025 ΔOwn +3.9%
+$915.9K
30,921 sh @ $30
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Dec 4, 2025 ΔOwn −3.7%

Mackin James P sold $1.41M of AORT, trimming their stake 4%.

−$1.41M
30,921 sh @ $45
AORT
Option exercise Mackin James P · President & CEO · Option exercise · filed Dec 3, 2025 ΔOwn +3.9%
+$915.9K
30,921 sh @ $30
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Dec 3, 2025 ΔOwn −3.7%

Mackin James P sold $1.41M of AORT, trimming their stake 4%.

−$1.41M
30,921 sh @ $46
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Nov 14, 2025 ΔOwn −4.1%

Mackin James P sold $1.57M of AORT, trimming their stake 4%.

−$1.57M
34,210 sh @ $46
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Nov 12, 2025 ΔOwn −2.1%

Mackin James P sold $784.4K of AORT, trimming their stake 2%.

−$784.4K
17,580 sh @ $45
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Aug 19, 2025 ΔOwn −1.4%

Mackin James P sold $529K of AORT, trimming their stake 1%.

−$529K
12,500 sh @ $42
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Mar 10, 2025 ΔOwn −2.0%

Mackin James P sold $440K of AORT, trimming their stake 2%.

−$440K
17,739 sh @ $25
AORT
Option exercise Mackin James P · President & CEO · Option exercise · filed Mar 10, 2025 ΔOwn +8.8%
+$1.63M
75,615 sh @ $22
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Mar 10, 2025 ΔOwn −7.6%

Mackin James P sold $1.75M of AORT, trimming their stake 8%.

−$1.75M
70,700 sh @ $25
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 26, 2025 ΔOwn −2.4%

Mackin James P sold $455K of AORT, trimming their stake 2%.

−$455K
16,664 sh @ $27
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 26, 2025 ΔOwn −2.0%

Mackin James P sold $376.4K of AORT, trimming their stake 2%.

−$376.4K
13,784 sh @ $27
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 26, 2025 ΔOwn −1.0%

Mackin James P sold $186K of AORT, trimming their stake 1%.

−$186K
6,812 sh @ $27
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 26, 2025 ΔOwn −0.7%

Mackin James P sold $133.7K of AORT, trimming their stake 1%.

−$133.7K
4,896 sh @ $27
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Mar 7, 2024 ΔOwn −1.9%

Mackin James P sold $262K of AORT, trimming their stake 2%.

−$262K
13,996 sh @ $19
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 29, 2024 ΔOwn −0.7%

Mackin James P sold $95.9K of AORT, trimming their stake 1%.

−$95.9K
4,837 sh @ $20
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 28, 2024 ΔOwn −2.7%

Mackin James P sold $367.8K of AORT, trimming their stake 3%.

−$367.8K
18,144 sh @ $20
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 28, 2024 ΔOwn −1.9%

Mackin James P sold $266.9K of AORT, trimming their stake 2%.

−$266.9K
13,168 sh @ $20
AORT
Option exercise Mackin James P · President & CEO · Option exercise · filed Feb 22, 2024 ΔOwn +11%
+$965.4K
59,225 sh @ $16
AORT
Sell Mackin James P · President & CEO · Open-market sale · filed Feb 22, 2024 ΔOwn −9.7%

Mackin James P sold $1.12M of AORT, trimming their stake 10%.

−$1.12M
59,225 sh @ $19

Frequently asked questions

How is Mackin James P's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Mackin James P's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.